Purdue Pharma, the maker of opioid OxyContin, reached a tentative deal Wednesday over its role in the nation’s opioid crisis. Sources say that Stamford, Connecticut-based Purdue will pay up to $12 billion over time and that the Sackler family will give up control of the company.
Consumer
OxyContin maker Purdue Pharma could file for bankruptcy as early as today: sources
More Videos
-
Why aren’t more foreign grocers in Canada? Lack of space a hurdle: Minister Champagne
-
Consumers gear up for Loblaw boycott as petition for investigation gains traction
-
Can Canada be a leader in mining critical minerals for EV battery supply chains?
-
David Soberman explains the movement to boycott Loblaw locations
-
Loblaws boycott picks up steam as resentment grows online
-
‘Historic’ $15B plan announced for Honda EV plants in Ontario
You are viewing an Accelerated Mobile Webpage.
View Original Article